{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:33:28Z","timestamp":1787063608276,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00259-024-06954-w","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:01:57Z","timestamp":1729641717000},"page":"823-835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification of metabolic progression and subtypes in progressive supranuclear palsy by PET molecular imaging"],"prefix":"10.1007","volume":"52","author":[{"given":"Haotian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-5150","authenticated-orcid":false,"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"issue":"2","key":"6954_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1055\/s-0034-1377058","volume":"34","author":"JC Steele","year":"2014","unstructured":"Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, Basal Ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Semin Neurol. 2014;34(2):129\u201350. https:\/\/doi.org\/10.1055\/s-0034-1377058.","journal-title":"Semin Neurol"},{"issue":"14","key":"6954_CR2","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek G, Stamelou M, Kurz C, et al. The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord off J Mov Disord Soc. 2014;29(14):1758\u201366. https:\/\/doi.org\/10.1002\/mds.26054.","journal-title":"Mov Disord off J Mov Disord Soc"},{"issue":"7","key":"6954_CR3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.27034","volume":"32","author":"G Respondek","year":"2017","unstructured":"Respondek G, Kurz C, Arzberger T, et al. Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord off J Mov Disord Soc. 2017;32(7):995\u20131005. https:\/\/doi.org\/10.1002\/mds.27034.","journal-title":"Mov Disord off J Mov Disord Soc"},{"issue":"Pt 6","key":"6954_CR4","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/brain\/awm104","volume":"130","author":"DR Williams","year":"2007","unstructured":"Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson\u2019s syndrome. Brain J Neurol. 2007;130(Pt 6):1566\u201376. https:\/\/doi.org\/10.1093\/brain\/awm104.","journal-title":"Brain J Neurol"},{"issue":"6","key":"6954_CR5","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams DR, De Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism. Brain. 2005;128(6):1247\u201358. https:\/\/doi.org\/10.1093\/brain\/awh488.","journal-title":"Brain"},{"issue":"7","key":"6954_CR6","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00415-019-09324-x","volume":"266","author":"M Picillo","year":"2019","unstructured":"The PSP Salerno study group, Picillo M, Cuoco S, et al. Motor, cognitive and behavioral differences in MDS PSP phenotypes. J Neurol. 2019;266(7):1727\u201335. https:\/\/doi.org\/10.1007\/s00415-019-09324-x.","journal-title":"J Neurol"},{"issue":"8","key":"6954_CR7","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.27408","volume":"33","author":"M Picillo","year":"2018","unstructured":"Picillo M, Erro R, Cuoco S, et al. MDS PSP criteria in real-life clinical setting: motor and cognitive characterization of subtypes: MDS PSP Criteria in Real-Life Clinical setting. Mov Disord. 2018;33(8):1361\u20135. https:\/\/doi.org\/10.1002\/mds.27408.","journal-title":"Mov Disord"},{"issue":"0","key":"6954_CR8","doi-asserted-by":"publisher","first-page":"0","DOI":"10.4103\/aian.AIAN_611_20","volume":"0","author":"R Mahale","year":"2021","unstructured":"Mahale R, Krishnan S, Divya K, Jisha V, Kishore A. Subtypes of PSP and prognosis: a retrospective analysis. Ann Indian Acad Neurol. 2021;0(0):0. https:\/\/doi.org\/10.4103\/aian.AIAN_611_20.","journal-title":"Ann Indian Acad Neurol"},{"issue":"6","key":"6954_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria: MDS Clinical Diagnostic Criteria for PSP. Mov Disord. 2017;32(6):853\u201364. https:\/\/doi.org\/10.1002\/mds.26987.","journal-title":"Mov Disord"},{"issue":"7","key":"6954_CR10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, H\u00f6glinger GU. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol. 2017;16(7):552\u201363. https:\/\/doi.org\/10.1016\/S1474-4422(17)30157-6.","journal-title":"Lancet Neurol"},{"issue":"3","key":"6954_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s43657-022-00089-4","volume":"3","author":"W Ying","year":"2023","unstructured":"Ying W. Phenomic studies on diseases: potential and challenges. Phenomics Cham Switz. 2023;3(3):285\u201399. https:\/\/doi.org\/10.1007\/s43657-022-00089-4.","journal-title":"Phenomics Cham Switz"},{"issue":"6","key":"6954_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/mdc3.12807","volume":"6","author":"F Ali","year":"2019","unstructured":"Ali F, Botha H, Whitwell JL, Josephs KA. Utility of the Movement Disorders Society Criteria for Progressive Supranuclear Palsy in Clinical Practice. Mov Disord Clin Pract. 2019;6(6):436\u20139. https:\/\/doi.org\/10.1002\/mdc3.12807.","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"6954_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","volume":"77","author":"E Jabbari","year":"2020","unstructured":"Jabbari E, Holland N, Chelban V, et al. Diagnosis across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. JAMA Neurol. 2020;77(3):377. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4347.","journal-title":"JAMA Neurol"},{"issue":"8","key":"6954_CR14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/mds.27666","volume":"34","author":"MJ Grimm","year":"2019","unstructured":"Grimm MJ, Respondek G, Stamelou M, et al. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov Disord off J Mov Disord Soc. 2019;34(8):1228\u201332. https:\/\/doi.org\/10.1002\/mds.27666.","journal-title":"Mov Disord off J Mov Disord Soc"},{"issue":"2","key":"6954_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00702-023-02591-z","volume":"130","author":"M Campagnolo","year":"2023","unstructured":"Campagnolo M, Weis L, Fogliano C, et al. Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes. J Neural Transm. 2023;130(2):97\u2013109. https:\/\/doi.org\/10.1007\/s00702-023-02591-z.","journal-title":"J Neural Transm"},{"issue":"6","key":"6954_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s43657-022-00083-w","volume":"3","author":"C Wang","year":"2023","unstructured":"Wang C, Shi Z, Li Y, et al. Protocol for Brain magnetic resonance imaging and extraction of imaging-derived phenotypes from the China Phenobank Project. Phenomics Cham Switz. 2023;3(6):642\u201356. https:\/\/doi.org\/10.1007\/s43657-022-00083-w.","journal-title":"Phenomics Cham Switz"},{"issue":"2","key":"6954_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol (Berl). 2020;140(2):99\u2013119. https:\/\/doi.org\/10.1007\/s00401-020-02158-2.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"6954_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/01.res.44.1.127","volume":"44","author":"M Reivich","year":"1979","unstructured":"Reivich M, Kuhl D, Wolf A, et al. The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979;44(1):127\u201337. https:\/\/doi.org\/10.1161\/01.res.44.1.127.","journal-title":"Circ Res"},{"issue":"1","key":"6954_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s43657-022-00077-8","volume":"3","author":"FT Liu","year":"2023","unstructured":"Liu FT, Lu JY, Sun YM, et al. Dopaminergic dysfunction and glucose metabolism characteristics in parkin-Induced early-Onset Parkinson\u2019s Disease compared to genetically undetermined early-Onset Parkinson\u2019s Disease. Phenomics Cham Switz. 2023;3(1):22\u201333. https:\/\/doi.org\/10.1007\/s43657-022-00077-8.","journal-title":"Phenomics Cham Switz"},{"issue":"8","key":"6954_CR20","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1007\/s00259-021-05234-1","volume":"48","author":"M Tian","year":"2021","unstructured":"Tian M, He X, Jin C, et al. Transpathology: molecular imaging-based pathology. Eur J Nucl Med Mol Imaging. 2021;48(8):2338\u201350. https:\/\/doi.org\/10.1007\/s00259-021-05234-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"6954_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s43657-022-00068-9","volume":"3","author":"M Tian","year":"2023","unstructured":"Tian M, Zuo C, Civelek AC, et al. International Nuclear Medicine Consensus on the clinical use of amyloid Positron Emission Tomography in Alzheimer\u2019s Disease. Phenomics Cham Switz. 2023;3(4):375\u201389. https:\/\/doi.org\/10.1007\/s43657-022-00068-9.","journal-title":"Phenomics Cham Switz"},{"issue":"11","key":"6954_CR22","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/mds.28217","volume":"35","author":"G Mart\u00ed-Andr\u00e9s","year":"2020","unstructured":"Mart\u00ed-Andr\u00e9s G, Bommel L, Meles SK, et al. Multicenter Validation of Metabolic Abnormalities Related to PSP according to the MDS\u2010PSP Criteria. Mov Disord. 2020;35(11):2009\u201318. https:\/\/doi.org\/10.1002\/mds.28217.","journal-title":"Mov Disord"},{"key":"6954_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3389\/fneur.2018.00483","volume":"9","author":"L Beyer","year":"2018","unstructured":"Beyer L, Meyer-Wilmes J, Sch\u00f6necker S, et al. Clinical routine FDG-PET imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: a gatekeeper for subsequent Tau-PET imaging? Front Neurol. 2018;9:483. https:\/\/doi.org\/10.3389\/fneur.2018.00483.","journal-title":"Front Neurol"},{"key":"6954_CR24","doi-asserted-by":"publisher","unstructured":"Zhao P, Zhang B, Gao S, Li X, Clinical. MRI and 18F-FDG-PET\/CT analysis of progressive supranuclear palsy. J Clin Neurosci. 2020;80:318\u201323. https:\/\/doi.org\/10.1016\/j.jocn.2020.06.008.","DOI":"10.1016\/j.jocn.2020.06.008"},{"issue":"7","key":"6954_CR25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mds.27038","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, H\u00f6glinger GU, Antonini A, et al. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Neuroimaging biomarkers for diagnosis in PSP. Mov Disord. 2017;32(7):955\u201371. https:\/\/doi.org\/10.1002\/mds.27038.","journal-title":"Mov Disord"},{"issue":"1","key":"6954_CR26","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference. Nat Commun. 2018;9(1):4273. https:\/\/doi.org\/10.1038\/s41467-018-05892-0.","journal-title":"Nat Commun"},{"key":"6954_CR27","doi-asserted-by":"publisher","unstructured":"Collij LE, Salvad\u00f3 G, Wottschel V, et al. Spatial-temporal patterns of \u03b2-Amyloid Accumulation: a subtype and stage inference Model Analysis. Neurology. 2022;98(17). https:\/\/doi.org\/10.1212\/WNL.0000000000200148.","DOI":"10.1212\/WNL.0000000000200148"},{"issue":"2","key":"6954_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00259-023-06403-0","volume":"51","author":"M Tian","year":"2024","unstructured":"Tian M, Zuo C, Cahid Civelek A, et al. International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism. Eur J Nucl Med Mol Imaging. 2024;51(2):434\u201342. https:\/\/doi.org\/10.1007\/s00259-023-06403-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6954_CR29","doi-asserted-by":"publisher","first-page":"117229","DOI":"10.1016\/j.neuroimage.2020.117229","volume":"222","author":"FJ L\u00f3pez-Gonz\u00e1lez","year":"2020","unstructured":"L\u00f3pez-Gonz\u00e1lez FJ, Silva-Rodr\u00edguez J, Paredes-Pacheco J, et al. Intensity normalization methods in brain FDG-PET quantification. NeuroImage. 2020;222:117229. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.117229.","journal-title":"NeuroImage"},{"key":"6954_CR30","doi-asserted-by":"publisher","first-page":"100811","DOI":"10.1016\/j.softx.2021.100811","volume":"16","author":"LM Aksman","year":"2021","unstructured":"Aksman LM, Wijeratne PA, Oxtoby NP, et al. pySuStaIn: a Python implementation of the subtype and stage inference algorithm. SoftwareX. 2021;16:100811. https:\/\/doi.org\/10.1016\/j.softx.2021.100811.","journal-title":"SoftwareX"},{"issue":"7","key":"6954_CR31","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/alz.12083","volume":"16","author":"NC Firth","year":"2020","unstructured":"Firth NC, Primativo S, Brotherhood E, et al. Sequences of cognitive decline in typical Alzheimer\u2019s disease and posterior cortical atrophy estimated using a novel event-based model of disease progression. Alzheimers Dement. 2020;16(7):965\u201373. https:\/\/doi.org\/10.1002\/alz.12083.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"6954_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1474-4422(10)70002-8","volume":"9","author":"CC Tang","year":"2010","unstructured":"Tang CC, Poston KL, Eckert T, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010;9(2):149\u201358. https:\/\/doi.org\/10.1016\/S1474-4422(10)70002-8.","journal-title":"Lancet Neurol"},{"issue":"2","key":"6954_CR33","doi-asserted-by":"publisher","first-page":"fcad048","DOI":"10.1093\/braincomms\/fcad048","volume":"5","author":"WJ Scotton","year":"2023","unstructured":"Scotton WJ, Shand C, Todd E, et al. Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning. Brain Commun. 2023;5(2):fcad048. https:\/\/doi.org\/10.1093\/braincomms\/fcad048.","journal-title":"Brain Commun"},{"key":"6954_CR34","doi-asserted-by":"publisher","first-page":"104835","DOI":"10.1016\/j.ebiom.2023.104835","volume":"97","author":"J Hong","year":"2023","unstructured":"Hong J, Lu J, Liu F, et al. Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [18F]Florzolotau PET imaging and subtype\/stage inference algorithm. EBioMedicine. 2023;97:104835. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104835.","journal-title":"EBioMedicine"},{"key":"6954_CR35","doi-asserted-by":"publisher","unstructured":"Jellinger KA. Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration. J Neural Transm Vienna Austria. 1996. https:\/\/doi.org\/10.1007\/s00702-023-02691-w. Published online September 2, 2023.","DOI":"10.1007\/s00702-023-02691-w"},{"issue":"4","key":"6954_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00702-023-02613-w","volume":"130","author":"KA Jellinger","year":"2023","unstructured":"Jellinger KA. Pathomechanisms of cognitive impairment in progressive supranuclear palsy. J Neural Transm Vienna Austria 1996. 2023;130(4):481\u201393. https:\/\/doi.org\/10.1007\/s00702-023-02613-w.","journal-title":"J Neural Transm Vienna Austria 1996"},{"issue":"12","key":"6954_CR37","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/mds.27198","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga S, Parks A, Kasanuki K, et al. Cognitive impairment in progressive supranuclear palsy is associated with tau burden. Mov Disord. 2017;32(12):1772\u20139. https:\/\/doi.org\/10.1002\/mds.27198.","journal-title":"Mov Disord"},{"key":"6954_CR38","doi-asserted-by":"publisher","unstructured":"Niu J, Zhong Y, Xue L, et al. Spatial-temporal dynamic evolution of lewy body dementia by metabolic PET imaging. Eur J Nucl Med Mol Imaging Published Online August. 2024;19. https:\/\/doi.org\/10.1007\/s00259-024-06881-w.","DOI":"10.1007\/s00259-024-06881-w"},{"issue":"2","key":"6954_CR39","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00259-023-06443-6","volume":"51","author":"C Xue","year":"2024","unstructured":"Xue C, Dou X, Yu C, et al. In vivo cerebral metabolic and dopaminergic characteristics in multiple system atrophy with orthostatic hypotension. Eur J Nucl Med Mol Imaging. 2024;51(2):468\u201380. https:\/\/doi.org\/10.1007\/s00259-023-06443-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6954_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.parkreldis.2021.01.015","volume":"84","author":"M Guasp","year":"2021","unstructured":"Guasp M, Molina-Porcel L, Painous C, et al. Association of PSP phenotypes with survival: a brain-bank study. Parkinsonism Relat Disord. 2021;84:77\u201381. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.01.015.","journal-title":"Parkinsonism Relat Disord"},{"key":"6954_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.parkreldis.2019.07.010","volume":"66","author":"A Shoeibi","year":"2019","unstructured":"Shoeibi A, Litvan I, Tolosa E, Ser TD, Lee E. Progression of two progressive supranuclear palsy phenotypes with comparable initial disability. Parkinsonism Relat Disord. 2019;66:87\u201393. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.07.010.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"6954_CR42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/cercor\/bhs397","volume":"24","author":"AC Tziortzi","year":"2014","unstructured":"Tziortzi AC, Haber SN, Searle GE, et al. Connectivity-based functional analysis of dopamine release in the Striatum using diffusion-weighted MRI and Positron Emission Tomography. Cereb Cortex. 2014;24(5):1165\u201377. https:\/\/doi.org\/10.1093\/cercor\/bhs397.","journal-title":"Cereb Cortex"},{"issue":"1\u20132","key":"6954_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jns.2013.03.006","volume":"329","author":"P Jokinen","year":"2013","unstructured":"Jokinen P, Karrasch M, Br\u00fcck A, Johansson J, Bergman J, Rinne JO. Cognitive slowing in Parkinson\u2019s disease is related to frontostriatal dopaminergic dysfunction. J Neurol Sci. 2013;329(1\u20132):23\u20138. https:\/\/doi.org\/10.1016\/j.jns.2013.03.006.","journal-title":"J Neurol Sci"},{"issue":"6","key":"6954_CR44","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1523\/JNEUROSCI.20-06-02369.2000","volume":"20","author":"SN Haber","year":"2000","unstructured":"Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci off J Soc Neurosci. 2000;20(6):2369\u201382. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-06-02369.2000.","journal-title":"J Neurosci off J Soc Neurosci"},{"issue":"1","key":"6954_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/jon.13045","volume":"33","author":"G Brown","year":"2023","unstructured":"Brown G, Hakun J, Lewis MM, et al. Frontostriatal and limbic contributions to cognitive decline in Parkinson\u2019s disease. J Neuroimaging off J Am Soc Neuroimaging. 2023;33(1):121\u201333. https:\/\/doi.org\/10.1111\/jon.13045.","journal-title":"J Neuroimaging off J Am Soc Neuroimaging"},{"issue":"9","key":"6954_CR46","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1093\/brain\/awad206","volume":"146","author":"DL Paulo","year":"2023","unstructured":"Paulo DL, Qian H, Subramanian D, et al. Corticostriatal beta oscillation changes associated with cognitive function in Parkinson\u2019s disease. Brain J Neurol. 2023;146(9):3662\u201375. https:\/\/doi.org\/10.1093\/brain\/awad206.","journal-title":"Brain J Neurol"},{"issue":"2","key":"6954_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pscychresns.2011.07.013","volume":"194","author":"JCL Looi","year":"2011","unstructured":"Looi JCL, Macfarlane MD, Walterfang M, et al. Morphometric analysis of subcortical structures in progressive supranuclear palsy: in vivo evidence of neostriatal and mesencephalic atrophy. Psychiatry Res. 2011;194(2):163\u201375. https:\/\/doi.org\/10.1016\/j.pscychresns.2011.07.013.","journal-title":"Psychiatry Res"},{"issue":"3","key":"6954_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/mds.23471","volume":"26","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Whitwell JL, Eggers SD, Senjem ML, Jack CR. Gray matter correlates of behavioral severity in progressive supranuclear palsy. Mov Disord off J Mov Disord Soc. 2011;26(3):493\u20138. https:\/\/doi.org\/10.1002\/mds.23471.","journal-title":"Mov Disord off J Mov Disord Soc"},{"issue":"2","key":"6954_CR49","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/brain\/awx347","volume":"141","author":"TE Cope","year":"2018","unstructured":"Cope TE, Rittman T, Borchert RJ, et al. Tau burden and the functional connectome in Alzheimer\u2019s disease and progressive supranuclear palsy. Brain J Neurol. 2018;141(2):550\u201367. https:\/\/doi.org\/10.1093\/brain\/awx347.","journal-title":"Brain J Neurol"},{"issue":"7","key":"6954_CR50","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s00259-024-06637-6","volume":"51","author":"C Ferschmann","year":"2024","unstructured":"Ferschmann C, Messerschmidt K, Gn\u00f6rich J, et al. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies. Eur J Nucl Med Mol Imaging. 2024;51(7):1909\u201322. https:\/\/doi.org\/10.1007\/s00259-024-06637-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"6954_CR51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ane.13653","volume":"146","author":"Q Chen","year":"2022","unstructured":"Chen Q, Li X, Li L, et al. Dopamine transporter imaging in progressive supranuclear palsy: severe but nonspecific to subtypes. Acta Neurol Scand. 2022;146(3):237\u201345. https:\/\/doi.org\/10.1111\/ane.13653.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"6954_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s13760-018-0993-x","volume":"119","author":"T Schirinzi","year":"2019","unstructured":"Schirinzi T, Pisani V, Imbriani P, Di Lazzaro G, Scalise S, Pisani A. Long-term treatment with rotigotine in drug-na\u00efve PSP patients. Acta Neurol Belg. 2019;119(1):113\u20136. https:\/\/doi.org\/10.1007\/s13760-018-0993-x.","journal-title":"Acta Neurol Belg"},{"key":"6954_CR53","doi-asserted-by":"publisher","first-page":"613261","DOI":"10.3389\/frai.2021.613261","volume":"4","author":"AL Young","year":"2021","unstructured":"Young AL, Vogel JW, Aksman LM, et al. Ordinal SuStaIn: subtype and stage inference for clinical scores, visual ratings, and other Ordinal Data. Front Artif Intell. 2021;4:613261. https:\/\/doi.org\/10.3389\/frai.2021.613261.","journal-title":"Front Artif Intell"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-06954-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T23:27:29Z","timestamp":1737502049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-06954-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["6954"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-06954-w","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Human Subject Research Ethics Committee of the Second Affiliated Hospital, Zhejiang University School of Medicine (Approval Number: 2019\u2009\u2212\u2009287).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Supplementary Fig.\u00a0\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None declared.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}},{"value":"Research involving Human Participants.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}